annual current liabilities:
$606.99M-$570.04M(-48.43%)Summary
- As of today (July 31, 2025), BMRN annual total current liabilities is $606.99 million, with the most recent change of -$570.04 million (-48.43%) on December 31, 2024.
- During the last 3 years, BMRN annual current liabilities has risen by +$60.49 million (+11.07%).
- BMRN annual current liabilities is now -48.43% below its all-time high of $1.18 billion, reached on December 31, 2023.
Performance
BMRN Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$628.21M+$21.23M(+3.50%)Summary
- As of today (July 31, 2025), BMRN quarterly total current liabilities is $628.21 million, with the most recent change of +$21.23 million (+3.50%) on March 31, 2025.
- Over the past year, BMRN quarterly current liabilities has dropped by -$459.69 million (-42.25%).
- BMRN quarterly current liabilities is now -46.63% below its all-time high of $1.18 billion, reached on December 31, 2023.
Performance
BMRN quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
BMRN Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.4% | -42.3% |
| 3 y3 years | +11.1% | +28.1% |
| 5 y5 years | -34.9% | -23.4% |
BMRN Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.4% | +11.1% | -46.6% | +35.2% |
| 5 y | 5-year | -48.4% | +23.2% | -46.6% | +46.1% |
| alltime | all time | -48.4% | >+9999.0% | -46.6% | >+9999.0% |
BMRN Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $628.21M(+3.5%) |
| Dec 2024 | $606.99M(-48.4%) | $606.99M(-15.2%) |
| Sep 2024 | - | $715.66M(-32.9%) |
| Jun 2024 | - | $1.07B(-1.9%) |
| Mar 2024 | - | $1.09B(-7.6%) |
| Dec 2023 | $1.18B(+99.9%) | $1.18B(+1.2%) |
| Sep 2023 | - | $1.16B(+94.8%) |
| Jun 2023 | - | $597.23M(-0.2%) |
| Mar 2023 | - | $598.23M(+1.6%) |
| Dec 2022 | $588.88M(+7.8%) | $588.88M(+13.0%) |
| Sep 2022 | - | $521.02M(+12.1%) |
| Jun 2022 | - | $464.73M(-5.2%) |
| Mar 2022 | - | $490.42M(-10.3%) |
| Dec 2021 | $546.50M(+11.0%) | $546.50M(+6.1%) |
| Sep 2021 | - | $514.90M(+16.1%) |
| Jun 2021 | - | $443.34M(+3.1%) |
| Mar 2021 | - | $430.04M(-12.7%) |
| Dec 2020 | $492.55M(-47.2%) | $492.55M(-42.4%) |
| Sep 2020 | - | $854.69M(+5.1%) |
| Jun 2020 | - | $813.30M(-0.9%) |
| Mar 2020 | - | $820.47M(-12.0%) |
| Dec 2019 | $932.50M(+78.2%) | $932.50M(+88.9%) |
| Sep 2019 | - | $493.75M(+12.4%) |
| Jun 2019 | - | $439.43M(-12.3%) |
| Mar 2019 | - | $500.99M(-4.3%) |
| Dec 2018 | $523.24M(-35.9%) | $523.24M(-37.6%) |
| Sep 2018 | - | $838.66M(+4.2%) |
| Jun 2018 | - | $804.95M(+4.1%) |
| Mar 2018 | - | $773.47M(-5.3%) |
| Dec 2017 | $816.52M(+85.9%) | $816.52M(+95.6%) |
| Sep 2017 | - | $417.53M(+11.5%) |
| Jun 2017 | - | $374.30M(+10.0%) |
| Mar 2017 | - | $340.21M(-22.6%) |
| Dec 2016 | $439.31M(-1.4%) | $439.31M(+16.4%) |
| Sep 2016 | - | $377.33M(+3.5%) |
| Jun 2016 | - | $364.58M(-6.0%) |
| Mar 2016 | - | $388.01M(-12.9%) |
| Dec 2015 | $445.46M(+89.0%) | $445.46M(+14.1%) |
| Sep 2015 | - | $390.49M(+12.3%) |
| Jun 2015 | - | $347.70M(+13.8%) |
| Mar 2015 | - | $305.51M(+29.6%) |
| Dec 2014 | $235.74M(+28.6%) | $235.74M(+14.1%) |
| Sep 2014 | - | $206.55M(+23.9%) |
| Jun 2014 | - | $166.72M(+6.8%) |
| Mar 2014 | - | $156.04M(-14.9%) |
| Dec 2013 | $183.27M(+7.5%) | $183.27M(+9.3%) |
| Sep 2013 | - | $167.63M(+17.9%) |
| Jun 2013 | - | $142.24M(-1.2%) |
| Mar 2013 | - | $144.01M(-15.5%) |
| Dec 2012 | $170.43M(+81.1%) | $170.43M(+26.3%) |
| Sep 2012 | - | $134.93M(+12.4%) |
| Jun 2012 | - | $120.00M(+0.2%) |
| Mar 2012 | - | $119.81M(+27.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $94.13M(+12.3%) | $94.13M(+13.1%) |
| Sep 2011 | - | $83.25M(+1.5%) |
| Jun 2011 | - | $82.03M(+8.0%) |
| Mar 2011 | - | $75.99M(-9.4%) |
| Dec 2010 | $83.84M(+7.3%) | $83.84M(-9.0%) |
| Sep 2010 | - | $92.10M(+9.7%) |
| Jun 2010 | - | $83.93M(+6.6%) |
| Mar 2010 | - | $78.70M(+0.7%) |
| Dec 2009 | $78.15M(-39.9%) | $78.15M(+22.0%) |
| Sep 2009 | - | $64.07M(+6.7%) |
| Jun 2009 | - | $60.03M(-52.5%) |
| Mar 2009 | - | $126.31M(-2.9%) |
| Dec 2008 | $130.08M(+111.4%) | $130.08M(+7.7%) |
| Sep 2008 | - | $120.73M(+90.4%) |
| Jun 2008 | - | $63.42M(+19.0%) |
| Mar 2008 | - | $53.31M(-13.4%) |
| Dec 2007 | $61.54M(+33.7%) | $61.54M(+25.4%) |
| Sep 2007 | - | $49.06M(+10.1%) |
| Jun 2007 | - | $44.54M(+14.7%) |
| Mar 2007 | - | $38.83M(-15.7%) |
| Dec 2006 | $46.05M(+14.1%) | $46.05M(+6.5%) |
| Sep 2006 | - | $43.23M(+13.7%) |
| Jun 2006 | - | $38.00M(-33.2%) |
| Mar 2006 | - | $56.89M(+40.9%) |
| Dec 2005 | $40.37M(-42.4%) | $40.37M(-8.7%) |
| Sep 2005 | - | $44.22M(+1.2%) |
| Jun 2005 | - | $43.70M(-13.8%) |
| Mar 2005 | - | $50.70M(-27.6%) |
| Dec 2004 | $70.05M(+446.7%) | $70.05M(-7.5%) |
| Sep 2004 | - | $75.72M(-6.8%) |
| Jun 2004 | - | $81.27M(+436.0%) |
| Mar 2004 | - | $15.16M(+18.3%) |
| Dec 2003 | $12.81M(+87.2%) | $12.81M(-21.1%) |
| Sep 2003 | - | $16.24M(+6.5%) |
| Jun 2003 | - | $15.25M(+19.9%) |
| Mar 2003 | - | $12.72M(+85.8%) |
| Dec 2002 | $6.85M(-17.5%) | $6.85M(-18.0%) |
| Sep 2002 | - | $8.35M(+8.0%) |
| Jun 2002 | - | $7.73M(-18.1%) |
| Mar 2002 | - | $9.44M(+13.6%) |
| Dec 2001 | $8.30M(+20.6%) | $8.30M(+36.3%) |
| Sep 2001 | - | $6.09M(+18.9%) |
| Jun 2001 | - | $5.12M(+40.9%) |
| Mar 2001 | - | $3.64M(-47.2%) |
| Dec 2000 | $6.88M(+35.3%) | $6.88M(+90.7%) |
| Sep 2000 | - | $3.61M(+27.7%) |
| Jun 2000 | - | $2.83M(-39.6%) |
| Mar 2000 | - | $4.68M(-8.0%) |
| Dec 1999 | $5.09M(+154.4%) | $5.09M(-9.2%) |
| Sep 1999 | - | $5.60M(-29.1%) |
| Jun 1999 | - | $7.90M(+393.8%) |
| Mar 1999 | - | $1.60M |
| Dec 1998 | $2.00M | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual total current liabilities?
- What is the all time high annual current liabilities for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual current liabilities year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly current liabilities year-on-year change?
What is BioMarin Pharmaceutical Inc. annual total current liabilities?
The current annual current liabilities of BMRN is $606.99M
What is the all time high annual current liabilities for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual total current liabilities is $1.18B
What is BioMarin Pharmaceutical Inc. annual current liabilities year-on-year change?
Over the past year, BMRN annual total current liabilities has changed by -$570.04M (-48.43%)
What is BioMarin Pharmaceutical Inc. quarterly total current liabilities?
The current quarterly current liabilities of BMRN is $628.21M
What is the all time high quarterly current liabilities for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly total current liabilities is $1.18B
What is BioMarin Pharmaceutical Inc. quarterly current liabilities year-on-year change?
Over the past year, BMRN quarterly total current liabilities has changed by -$459.69M (-42.25%)